Original Source(s)
Related Content
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min
Sex Disparities May Persist in CF Despite Modulators
Review findings suggested female patients with cystic fibrosis may continue to experience worse pulmonary outcomes despite highly effective modulator therapy
May 22, 2026
-
6 min
FDA Approves Expanded Liquid Biopsy Panel
Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.
May 20, 2026
-
2 min